FDI in pharmaceuticals: The state of play
The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage…
By
The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage…
ByThe latest expansion will create more than 250 new high-skilled manufacturing jobs at the company’s Kalamazoo facility.
The company does not anticipate any supply chain disruptions or price pressure due to the Russia-Ukraine crisis.
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
ByThe UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK…
ByNorwegian vaccine and immunotherapy-focused biopharma Vaccibody has rebranded to Nykode after signing a nearly $1bn deal.
ByAION Labs will create and invest in early-stage start-ups developing AI and computational solutions to major challenges in pharma.
ByWith COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?
ByThank you for subscribing to Pharmaceutical Technology